Genesystem Statistics
Total Valuation
Genesystem has a market cap or net worth of KRW 61.96 billion. The enterprise value is 63.04 billion.
Market Cap | 61.96B |
Enterprise Value | 63.04B |
Important Dates
The next estimated earnings date is Thursday, June 19, 2025.
Earnings Date | Jun 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Genesystem has 7.03 million shares outstanding. The number of shares has decreased by -2.33% in one year.
Current Share Class | 7.03M |
Shares Outstanding | 7.03M |
Shares Change (YoY) | -2.33% |
Shares Change (QoQ) | +0.27% |
Owned by Insiders (%) | 18.39% |
Owned by Institutions (%) | 17.61% |
Float | 5.74M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 54.54 |
PB Ratio | 3.11 |
P/TBV Ratio | 5.73 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.40 |
EV / Sales | 55.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -8.45 |
Financial Position
The company has a current ratio of 3.23, with a Debt / Equity ratio of 0.21.
Current Ratio | 3.23 |
Quick Ratio | 2.22 |
Debt / Equity | 0.21 |
Debt / EBITDA | n/a |
Debt / FCF | -0.56 |
Interest Coverage | -71.50 |
Financial Efficiency
Return on equity (ROE) is -37.80% and return on invested capital (ROIC) is -21.06%.
Return on Equity (ROE) | -37.80% |
Return on Assets (ROA) | -18.55% |
Return on Invested Capital (ROIC) | -21.06% |
Return on Capital Employed (ROCE) | -37.61% |
Revenue Per Employee | 21.04M |
Profits Per Employee | -157.83M |
Employee Count | 54 |
Asset Turnover | 0.04 |
Inventory Turnover | 0.97 |
Taxes
Income Tax | -150.73M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.92% in the last 52 weeks. The beta is 0.55, so Genesystem's price volatility has been lower than the market average.
Beta (5Y) | 0.55 |
52-Week Price Change | +10.92% |
50-Day Moving Average | 9,910.00 |
200-Day Moving Average | 9,940.30 |
Relative Strength Index (RSI) | 29.31 |
Average Volume (20 Days) | 30,544 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genesystem had revenue of KRW 1.14 billion and -8.52 billion in losses. Loss per share was -1,253.31.
Revenue | 1.14B |
Gross Profit | -1.60B |
Operating Income | -9.59B |
Pretax Income | -9.28B |
Net Income | -8.52B |
EBITDA | -8.38B |
EBIT | -9.59B |
Loss Per Share | -1,253.31 |
Balance Sheet
The company has 5.52 billion in cash and 4.15 billion in debt, giving a net cash position of 1.36 billion or 193.89 per share.
Cash & Cash Equivalents | 5.52B |
Total Debt | 4.15B |
Net Cash | 1.36B |
Net Cash Per Share | 193.89 |
Equity (Book Value) | 19.95B |
Book Value Per Share | 2,488.73 |
Working Capital | 5.67B |
Cash Flow
In the last 12 months, operating cash flow was -7.14 billion and capital expenditures -321.63 million, giving a free cash flow of -7.46 billion.
Operating Cash Flow | -7.14B |
Capital Expenditures | -321.63M |
Free Cash Flow | -7.46B |
FCF Per Share | -1,060.92 |
Margins
Gross Margin | -140.99% |
Operating Margin | -844.57% |
Pretax Margin | -817.05% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Genesystem does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 2.33% |
Shareholder Yield | n/a |
Earnings Yield | -13.76% |
FCF Yield | -12.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Genesystem has an Altman Z-Score of 3.96 and a Piotroski F-Score of 3.
Altman Z-Score | 3.96 |
Piotroski F-Score | 3 |